Enzon Pharmaceuticals Inc (ENZN)
0.09
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Enzon Pharmaceuticals Free Cash Flow: 1.305M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.305M |
| September 30, 2023 | 0.98M |
| June 30, 2023 | 0.612M |
| March 31, 2023 | -0.277M |
| December 31, 2022 | -0.659M |
| September 30, 2022 | -1.039M |
| June 30, 2022 | -1.397M |
| March 31, 2022 | -0.758M |
| December 31, 2021 | -0.501M |
| September 30, 2021 | -0.796M |
| June 30, 2021 | -0.794M |
| March 31, 2021 | -0.033M |
| December 31, 2020 | -0.38M |
| September 30, 2020 | 0.901M |
| June 30, 2020 | 7.848M |
| March 31, 2020 | 6.892M |
| December 31, 2019 | 6.905M |
| September 30, 2019 | 5.943M |
| June 30, 2019 | -0.946M |
| March 31, 2019 | -1.029M |
| December 31, 2018 | -0.978M |
| September 30, 2018 | 2.406M |
| June 30, 2018 | 2.392M |
| March 31, 2018 | 5.793M |
| December 31, 2017 | 6.471M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.688M |
| June 30, 2017 | 6.607M |
| March 31, 2017 | 4.976M |
| December 31, 2016 | 2.599M |
| September 30, 2016 | 3.695M |
| June 30, 2016 | 5.383M |
| March 31, 2016 | 8.076M |
| December 31, 2015 | 14.68M |
| September 30, 2015 | 22.19M |
| June 30, 2015 | 26.36M |
| March 31, 2015 | 28.80M |
| December 31, 2014 | 32.34M |
| September 30, 2014 | 26.25M |
| June 30, 2014 | 25.60M |
| March 31, 2014 | 19.46M |
| December 31, 2013 | 14.00M |
| September 30, 2013 | 16.50M |
| June 30, 2013 | 15.09M |
| March 31, 2013 | 11.70M |
| December 31, 2012 | 8.429M |
| September 30, 2012 | -2.058M |
| June 30, 2012 | -11.24M |
| March 31, 2012 | -14.81M |
| December 31, 2011 | -13.36M |
| September 30, 2011 | -23.02M |
Free Cash Flow Range, Past 5 Years
-1.397M
Minimum
Jun 2022
7.848M
Maximum
Jun 2020
1.253M
Average
-0.277M
Median
Mar 2023
Free Cash Flow Benchmarks
| AIM ImmunoTech Inc | -21.85M |
| Perspective Therapeutics Inc | -37.98M |
| Protalix BioTherapeutics Inc | -2.467M |
| Electromed Inc | 3.653M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.455M |
| Free Cash Flow Per Share (Quarterly) | 0.0061 |
| Free Cash Flow Yield | 19.54% |